ORCID as entered in ROS

Select Publications
2016, 'Utility of Extremity Magnetic Resonance Imaging (eMRI) without Contrast Enhancement in Detecting Preclinical Psoriatic Arthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, DC, Washington, presented at Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Health-Professionals (ACR/ARHP), DC, Washington, 11 November 2016 - 16 November 2016
,2016, 'APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104 WEEK) IMPROVEMENT IN FATIGUE IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS', in RHEUMATOLOGY, OXFORD UNIV PRESS, SCOTLAND, Glasgow, pp. 140 - 141, presented at Annual Meeting of the British-Society-for-Rheumatology, British-Health-Professionals-in-Rheumatology and the British-Society-for-Paediatric-and-Adolescent-Rheumatology (Rheumatology), SCOTLAND, Glasgow, 26 April 2016 - 28 April 2016
,2016, 'EFFECT OF CALIBRATION AND TRAINING ON MAGNETIC RESONANCE IMAGING SACROILIITIS SCORING AND SI JOINT RADIOGRAPHIC SCORING AGREEMENT', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000375046500111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'TOFACITINIB: TREATMENT OUTCOMES IN SEROPOSITIVE VERSUS SERONEGATIVE PATIENTS IN A PHASE 3 RHEUMATOID ARTHRITIS POPULATION', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000375046500092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'A RETROSPECTIVE NON-INTERVENTIONAL STUDY ON THE USE OF BIOLOGICS IN THE TREATMENT OF AUSTRALIAN PATIENTS WITH RHEUMATOID ARTHRITIS: THE REAL STUDY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 31 - 31
,2016, 'THE PARA STUDY: A MULTI-CENTRE, CROSS-SECTIONAL STUDY OF PATIENTS TREATED WITH CASPAR-VALIDATED PSORIATIC ARTHRITIS IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 38 - 38
,2016, 'Development and validation of the OMERACT rheumatoid arthritis magnetic resonance tenosynovitis scoring system in a multireader exercise', in Journal of Rheumatology, Whistler, British Columbia, Canada, pp. 1688 - 1693, presented at OMERACT 2016 — International Consensus Conference on Outcome Measures in Rheumatology, Whistler, British Columbia, Canada, - , http://dx.doi.org/10.3899/jrheum.161097
,2016, 'The OMERACT rheumatoid arthritis magnetic resonance imaging (MRI) scoring system: Updated recommendations by the OMERACT MRI in arthritis working group', in Journal of Rheumatology, Whistler, British Columbia, Canada, pp. 1706 - 1712, presented at OMERACT 2016 — International Consensus Conference on Outcome Measures in Rheumatology, Whistler, British Columbia, Canada, - , http://dx.doi.org/10.3899/jrheum.161433
,2016, 'Validation of a knowledge transfer tool according to the OMERACT filter: Does web-based real-time iterative calibration enhance the evaluation of bone marrow lesions in hip osteoarthritis?', in Journal of Rheumatology, Whistler, British Columbia, Canada, pp. 1713 - 1717, presented at OMERACT 2016 — International Consensus Conference on Outcome Measures in Rheumatology, Whistler, British Columbia, Canada, - , http://dx.doi.org/10.3899/jrheum.161101
,2016, 'Validation of a knowledge transfer tool for the knee inflammation MRI scoring system for bone marrow lesions according to the OMERACT filter: Data from the osteoarthritis initiative', in Journal of Rheumatology, Whistler, British Columbia, Canada, pp. 1718 - 1722, presented at OMERACT 2016 – International Consensus Conference on Outcome Measures in Rheumatology, Whistler, British Columbia, Canada, - , http://dx.doi.org/10.3899/jrheum.161102
,2016, 'Whole-body magnetic resonance imaging in inflammatory arthritis: Systematic literature review and first steps toward standardization and an omeract scoring system', in Journal of Rheumatology, Whistler, British Columbia, Canada, pp. 1699 - 1705, presented at OMERACT 2016 — International Consensus Conference on Outcome Measures in Rheumatology, Whistler, British Columbia, Canada, - , http://dx.doi.org/10.3899/jrheum.161114
,2015, 'Baseline MRI and CRP As Predictors of Response to Etanercept in the Management of Patients with Non-Radiographic Axial Spondyloarthritis (nr-axSpA)', in ARTHRITIS & RHEUMATOLOGY, WILEY, CA, San Francisco, presented at Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), CA, San Francisco, 06 November 2015 - 11 November 2015
,2015, 'BASELINE MRI/CRP AS PREDICTORS OF RESPONSE TO ETANERCEPT IN THE MANAGEMENT OF PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'A RETROSPECTIVE REVIEW OF DISPENSING OF BIOLOGICS PRESCRIBED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE AUSTRALIAN POPULATION', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 30 - 30
,2015, 'COMPREHENSIVE SUMMARY OF THE EFFICACY AND SAFETY OF TOFACITINIB 5 MG TWICE DAILY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 29 - 29
,2015, 'LONG-TERM (104-WEEK) EFFICACY AND SAFETY OF APREMILAST MONOTHERAPY IN DMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: A PHASE 3, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 4)', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 40 - 40
,2015, 'LONG-TERM (104-WEEK) EFFICACY AND SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION (PALACE 1)', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 39 - 40
,2015, 'MULTI-CENTRE, CROSS-SECTIONAL, OBSERVATIONAL, RETROSPECTIVE STUDY OF PSORIATIC ARTHRITIS PATIENTS TREATED IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 39 - 39
,2014, 'A Phase 3, Randomized, Controlled Trial of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Treatment of Psoriatic Arthritis: Long-Term (52-Week) Improvements in Physical Function.', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S264 - S265, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Improvement of Pain, Fatigue, and Disability in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S691 - S691, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in the Signs and Symptoms of Psoriatic Arthritis in DMARD-Naive Patients: Results from a Phase 3, Randomized, Controlled Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S680 - S680, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S694 - S695, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Comprehensive Summary of the Efficacy and Safety of Tofacitinib 5mg Twice Daily in Patients with Rheumatoid Arthritis and an Inadequate Response to Disease-Modifying Antirheumatic Drugs', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S197 - S198, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Novel Quantification of MRI Provides a More Sensitive Outcome Measure Than Ramris.', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S517 - S518, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Validation of the Omeract Psoriatic Arthritis Magnetic Resonance Imaging Score for the Hand and Foot in a Randomized Placebo-Controlled Trial.', in ARTHRITIS & RHEUMATOLOGY, WILEY, MA, Boston, pp. S520 - S521, presented at 78th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), MA, Boston, 14 November 2014 - 19 November 2014
,2014, 'Efficacy of Biologic Medications in Active Rheumatoid Arthritis: A Systematic Review.', in ARTHRITIS & RHEUMATOLOGY, WILEY-BLACKWELL, pp. S1055 - S1055, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344384905097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'RHEUMATOID ARTHRITIS PATIENTS IN AUSTRALIAN DATABASE SHOW SIGNIFICANT IMPROVEMENT IN DISEASE ACTIVITY OVER 5 YEARS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334281900090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS OF PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS (PALACE 1, 2, AND 3)', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 19 - 19
,2014, 'DESIGN OF AC-CUTE: AN OPEN-LABEL STUDY TO EVALUATE NON-PROGRESSION OF STRUCTURAL JOINT DAMAGE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 26 - 26
,2014, 'EXAMINATION OF THE EFFECTIVENESS OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING FOR IDENTIFYING POOR PROGNOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 30 - 30
,2014, 'Long-Term (104-Week) Safety and Efficacy of Monotherapy with Apremilast in DMARD-Naive Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (PALACE 4)', in ARTHRITIS & RHEUMATOLOGY, WILEY-BLACKWELL, pp. 3539 - 3539
,2013, 'Apremilast in the Treatment of DMARD-Naive Psoriatic Arthritis Patients: Results of a Phase 3 Randomized, Controlled Trial (PALACE 4)', in ARTHRITIS AND RHEUMATISM, WILEY-BLACKWELL, CA, San Diego, pp. 3320 - 3321, presented at 77th Annual Meeting of the American-College-of-Rheumatology (ACR) / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), CA, San Diego, 25 October 2013 - 30 October 2013
,2013, 'A LONGITUDINAL STUDY OF THE CLINICAL EFFECTS OF CONVENTIONAL AND BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN AUSTRALIAN RHEUMATOLOGY PRACTICE', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, SPAIN, Madrid, pp. 1028 - 1028, presented at Annual European Congress of Rheumatology (EULAR), SPAIN, Madrid, 12 June 2013 - 15 June 2013
,2013, 'A LONGITUDINAL STUDY OF PROGNOSTIC FACTORS IN PATIENTS WITH EARLY RA PROVIDING DIRECTION FOR FUTURE CLINICAL TREATMENT-PREDICT STUDY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 2 - 3
,2013, 'A LONGITUDINAL STUDY OF THE CLINICAL EFFECTS OF CONVENTIONAL AND BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN AUSTRALIAN RHEUMATOLOGY PRACTICE', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 12 - 12
,2013, 'SUMMACTA: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY OF THE SAFETY AND EFFICACY OF TOCILIZUMAB SUBCUTANEOUS (SC) VERSUS TOCILIZUMAB INTRAVENOUS (IV), IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS (RA)', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 13 - 13
,2013, 'THE OMERACT-RAMRIS RHEUMATOID ARTHRITIS MAGNETIC RESONANCE IMAGING JOINT SPACE NARROWING SCORE (RAMRIS JSN) IS REPRODUCIBLE AND CORRELATES CLOSELY WITH COMPUTED TOMOGRAPHY ASSESSMENT', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, pp. 52 - 52
,2012, 'A Longitudinal Study of Prognostic Factors in Patients with Early RA Providing Direction for Future Clinical Treatment- Predict Study.', in ARTHRITIS AND RHEUMATISM, WILEY-BLACKWELL, DC, Washington, pp. S905 - S906, presented at Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), DC, Washington, 09 November 2012 - 14 November 2012
,2012, 'Medication Choices and Medication Survival in a National Multicentre Community Based Rheumatoid Arthritis Cohort.', in ARTHRITIS AND RHEUMATISM, WILEY-BLACKWELL, DC, Washington, pp. S169 - S169, presented at Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), DC, Washington, 09 November 2012 - 14 November 2012
,2012, 'Discovering Indicators for Congestion in DBMSs', in 2012 IEEE 28th International Conference on Data Engineering Workshops, IEEE, pp. 263 - 268, presented at 2012 IEEE International Conference on Data Engineering Workshops (ICDEW), 01 April 2012 - 05 April 2012, http://dx.doi.org/10.1109/icdew.2012.50
,2012, 'COMPARISON OF TOCILIZUMAB AS MONOTHERAPY OR WITH ADD-ON DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO PREVIOUS TREATMENTS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 13 - 14
,2012, 'DAS IN AUSTRALIAN RA PATIENTS INVERSELY RELATES TO SOCIOECONOMIC STATUS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 15 - 16
,2012, 'IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS: AUSTRALIAN RESULTS FROM THE INDUCTION PERIOD OF PRESERVE TRIAL', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 12 - 13
,2012, 'MRI CHANGES IN PSORIATIC ARTHRITIS IN THE FIRST 12 WEEKS OF ANTI TNF THERAPY: COMPARISON OF HIGH AND LOW FIELD IMAGES', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 18 - 18
,2012, 'Validation of the newly proposed OMERACT joint space narrowing scoring system in rheumatoid arthritis wrist and metacarpophalangeal joints', in SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, INFORMA HEALTHCARE, pp. 23 - 24
,2011, 'The use of economic models to capture importance policy for autonomic database management systems', in Proceedings of the 1st ACM/IEEE workshop on Autonomic computing in economics, ACM, pp. 3 - 10, presented at ICAC '11: 8th International Conference on Autonomic Computing, http://dx.doi.org/10.1145/1998561.1998564
,2011, 'Utility Function-based Workload Management for DBMSs', in Galis A; Dillenseger B (ed.), PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTONOMIC AND AUTONOMOUS SYSTEMS (ICAS 2011), IARIA XPS PRESS, ITALY, Venice, pp. 116 - 121, presented at 7th International Conference on Autonomic and Autonomous Systems (ICAS), ITALY, Venice, 22 May 2011 - 27 May 2011
,2011, 'EVIDENCE-BASED RECOMMENDATIONS FOR THE INVESTIGATION AND FOLLOW UP OF UNDIFFERENTIATED PERIPHERAL INFLAMMATORY ARTHRITIS - THE AUSTRALIA NEW ZEALAND 3E INITIATIVE', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'A LONGITUDINAL STUDY OF PROGNOSTIC FACTORS IN PATIENTS WITH EARLY RA PROVIDING DIRECTION FOR FUTURE CLINICAL TREATMENT- THE PREDICT STUDY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 16 - 17
,2011, 'OPTIMISING PATIENT OUTCOMES IN AUSTRALIAN RHEUMATOLOGY (OPAL) - A QUALITY USE OF MEDICINES INITIATIVE (QUMI) WITH > 7000 RHEUMATOID ARTHRITIS (RA) PATIENTS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 19 - 19
,